Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 7 clinical trials
Comparison of New-onset Diabetes After Transplantation Between Two Steroid Withdrawal Group With CellCept

With improvements in patient and graft survival, increasing attention has been placed on complications that contribute to long-term patient morbidity and mortality. New-onset diabetes after transplantation (NODAT) is a common complication of solid-organ transplantation, and is a strong predictor of graft failure and cardiovascular mortality in the transplant population. Risk …

insulin
insulin resistance
  • 0 views
  • 08 Nov, 2020
  • 1 location
Intracoronary Analysis of Cardiac Allograft Vasculopathy by Means of Optical Coherence Tomography

Randomized prospective multi-center imaging study which investigates the impact of different immunosuppressive protocols (Everolimus (Certican) or Mycophenolate mofetil (CellCept)) on cardiac

everolimus
cellcept
immunosuppressive agents
mycophenolate
heart transplantation
  • 1 views
  • 07 Nov, 2020
  • 1 location
Use of Acthar in Patients With FSGS That Will be Undergoing Renal Transplantation

This study will evaluate the use of Acthar in patients to undergo renal transplantation and will measure the rate of FSGS recurrence.

acthar
kidney transplant
  • 33 views
  • 27 Jan, 2021
  • 1 location
Thymoglobulin in Calcineurin Inhibitor and Steroid Minimization Protocol

This study has been designed to test whether using Thymoglobulin with low dose Cyclosporine and early steroid dosage reduction will minimize both kidney rejection and the development of new onset diabetes mellitus after renal transplant.

single kidney
thymoglobulin
calcineurin inhibitor
cyclosporine
kidney transplant
  • 21 views
  • 07 Nov, 2020
  • 3 locations
PK Study in Diabetic Transplant r cipients : From Twice-daily Tacrolimus to Once-daily Extended-release Tacrolimus

The investigators believe that the pharmacological properties of Envarsus, well studied in kidney transplantation, may be also suitable after simultaneous kidney and pancreas transplantation than Prograf. Indeed, Envarsus has demonstrated a clinical efficacy and safety in a complete clinical development plan. This study is to establish the pharmacokinetic profile of …

end-stage renal disease
chronic kidney disease (ckd)
kidney transplant
renal failure
prograf
  • 0 views
  • 25 Jan, 2021
  • 1 location
Mesenchymal Stromal Cells in Living Donor Kidney Transplantation

Kidney transplantation is a good treatment option for people with kidney disease. However, there is still much to learn about how to best care for the transplanted kidney and keep it functioning for a long time. Transplant recipients receive induction therapy and immunosuppression (anti-rejection) drugs to prevent their body from …

tacrolimus
immunosuppression
mycophenolate
basiliximab
nephropathy
  • 25 views
  • 28 Jan, 2021
  • 1 location
Islet Transplantation Using PKX-001

Islet Transplantation is a procedure used in people with difficult to control Type 1 Diabetes. Insulin producing cells (islets) are isolated from a deceased donor pancreas. After the cells are carefully isolated from the donor pancreas, the islets are transplanted into the recipient's liver. These transplanted islets may produce insulin. …

diabetes
severe hypoglycaemia
insulin
etanercept
plasma glucose
  • 86 views
  • 05 May, 2021
  • 1 location